Peliosis hepatis physical examination: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
|||
(One intermediate revision by the same user not shown) | |||
Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
Physical examination of patients with Peliosis Hepatis is usually normal. | |||
==Physical Examination== | ==Physical Examination== | ||
Physical examination of patients with Peliosis Hepatis is usually normal. Other physical examination might include Hepatomegaly which should prompt further diagnosis. <ref name="pmidhttps://www.e-cmh.org/m/journal/view.php?number=11">{{cite journal| author=Lefkowitz RJ| title=Identification of adenylate cyclase-coupled beta-adrenergic receptors with radiolabeled beta-adrenergic antagonists. | journal=Biochem Pharmacol | year= 1975 | volume= 24 | issue= 18 | pages= 1651-8 | pmid=https://www.e-cmh.org/m/journal/view.php?number=11 | doi=10.1016/0006-2952(75)90001-5 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11 }} </ref> | |||
==References== | ==References== |
Latest revision as of 22:49, 24 January 2021
Peliosis hepatis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Peliosis hepatis physical examination On the Web |
American Roentgen Ray Society Images of Peliosis hepatis physical examination |
Risk calculators and risk factors for Peliosis hepatis physical examination |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Physical examination of patients with Peliosis Hepatis is usually normal.
Physical Examination
Physical examination of patients with Peliosis Hepatis is usually normal. Other physical examination might include Hepatomegaly which should prompt further diagnosis. [1]
References
- ↑ Lefkowitz RJ (1975). "Identification of adenylate cyclase-coupled beta-adrenergic receptors with radiolabeled beta-adrenergic antagonists". Biochem Pharmacol. 24 (18): 1651–8. doi:10.1016/0006-2952(75)90001-5. PMID https://www.e-cmh.org/m/journal/view.php?number=11 Check
|pmid=
value (help).